Clinical Trials Browser

Phase 2 × Completed × Histone Deacetylase Inhibitors × Clear all

NCT01460940 2017-11-14

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase 2 Completed

24 enrolled 7 charts

Hodgkin Disease

NCT00185302 2015-12-14

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Phase 2 Completed

Melanoma

NCT00005624 2012-09-25

CI-994 in Treating Patients With Advanced Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell